Neurosoft Bioelectronics
Neurosoft Bioelectronics

Neurosoft Bioelectronics

Agent58Agent Readiness: 58/100. Top 25%. Measured by StartupHub.ai. Median 41.Speed94Site Speed: 94/100. Top 25%. Measured by Google PageSpeed. Median 62.

Developing soft, stretchable brain-computer interface platforms.

Website
2021Active18Geneva, Switzerland

About

Neurosoft Bioelectronics is a startup focused on creating advanced brain-computer interface (BCI) technology. Their core innovation lies in developing soft and stretchable BCI platforms designed for seamless integration with the brain. The company recently secured a $7.5 million oversubscribed seed funding round to accelerate the scaling of its technology.

Key facts

At-a-glance profile data

Website
neurosoftbio.com
Headquarters
Geneva, Switzerland
Founded
2021
Employees
18
Total funding
$8M (Seed)
Business model
B2B

Funding rounds

Funding rounds raised by Neurosoft Bioelectronics
DateRoundAmountLead investors
1 Jan 2023Seed$8M-

Tech stack

Detected on neurosoftbio.com, last scanned 22 Sept 2026. Run your own scan

Hosting
AWS
Add first review

Frequently asked

How much funding has Neurosoft Bioelectronics raised?

Neurosoft Bioelectronics has raised a total of $8M in funding. The most recent round on record is Seed.

How many employees does Neurosoft Bioelectronics have?

Neurosoft Bioelectronics has approximately 18 people on record.